Growth Metrics

Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2016 - 2026)

Zimmer Biomet Holdings has reported Total Non-Current Liabilities over the past 18 years, most recently at $9.4 billion for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities fell 2.42% year-over-year to $9.4 billion; the TTM value through Mar 2026 reached $9.4 billion, down 2.42%, while the annual FY2025 figure was $9.8 billion, 12.07% up from the prior year.
  • Total Non-Current Liabilities for Q1 2026 was $9.4 billion at Zimmer Biomet Holdings, down from $9.8 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $9.9 billion in Q3 2025 and troughed at $7.6 billion in Q2 2024.
  • A 5-year average of $8.7 billion and a median of $8.5 billion in 2022 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: dropped 20.99% in 2022 and later rose 24.94% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $8.4 billion in 2022, then dropped by 3.85% to $8.1 billion in 2023, then rose by 7.74% to $8.7 billion in 2024, then rose by 12.07% to $9.8 billion in 2025, then dropped by 3.59% to $9.4 billion in 2026.
  • Business Quant data shows Total Non-Current Liabilities for ZBH at $9.4 billion in Q1 2026, $9.8 billion in Q4 2025, and $9.9 billion in Q3 2025.